èšåºæ®µéã®ãã€ãªãã¯ãããžãŒäŒæ¥ã§ãã REGENXBIO Inc. ã¯ãéºäŒåæ¬ é¥ã«å¯ŸåŠããããã«çްèã«éºäŒåãééããããçŸæ£ã«åœ±é¿ãäžããããšãç®çãšããæ²»ççšã¿ã³ãã¯è³ªãŸãã¯æäœãäœå
ã®çްèãçæã§ããããã«ããããã®éºäŒåæ²»ç補ååè£ãæäŸããŠããŸããå瀟ã®éºäŒåæ²»ç補ååè£ã¯ãç¬èªã®ã¢ããé䌎ãŠã€ã«ã¹éºäŒåééãã©ãããã©ãŒã ã§ãã NAV ãã¯ãããžãŒ ãã©ãããã©ãŒã ã«åºã¥ããŠããŸããå瀟ã®äž»å補ååè£ã¯ RGX-314 ã§ã滲åºåå éœ¢é»æå€æ§çã®æ²»çè¬ãšããŠç¬¬ I/IIa çžèšåºè©Šéšäžã§ãããŸããã ã³å€ç³ç II åã®æ²»çè¬ãšããŠç¬¬ I/II çžèšåºè©Šéšäžã® RGX-121ãã ã³å€ç³ç I åã®æ²»çè¬ãšããŠç¬¬ I çžèšåºè©Šéšäžã® RGX-111ãä¹³å
åŸæç¥çµæ§ã»ãã€ããªããã¹ãã³ç II åçŸæ£ã®æ²»çè¬ãšã㊠RGX-181 ãéçºäžã§ãããŸããå®¶ææ§é«ã³ã¬ã¹ãããŒã«è¡çãã¢æ¥åäœã®æ²»çè¬ãšããŠç¬¬ I/II çžèšåºè©Šéšäžã® RGX-501 ããããŸããREGENXBIO Inc. ã¯ãNAV ãã¯ãããžãŒ ãã©ãããã©ãŒã ãä»ã®ãã€ãªãã¯ãããžãŒäŒæ¥ã補è¬äŒæ¥ã«ã©ã€ã»ã³ã¹äŸäžããŠãããç¥çµå€æ§çŸæ£ã®æ²»çè¬ãšããŠãã¯ã¿ãŒåæäœãéçºãããããNeurimmune AG ãšææºããã³ã©ã€ã»ã³ã¹å¥çŽãçµãã§ããŸããå瀟ã¯ä»¥å㯠ReGenX Biosciences, LLC ãšããŠç¥ãããŠããŸãããã2014 幎 9 æã« REGENXBIO Inc. ã«ç€Ÿåã倿ŽããŸãããREGENXBIO Inc. 㯠2008 幎ã«èšç«ãããã¡ãªãŒã©ã³ãå·ããã¯ãã«ã«æ¬ç€Ÿã眮ããŠããŸãã